These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 8142317)
21. Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells. Hirota K; Okawa H; Appadu BL; Grandy DK; Devi LA; Lambert DG Anesthesiology; 1999 Jan; 90(1):174-82. PubMed ID: 9915326 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological effects of naltriben as a ligand for opioid mu and kappa receptors in rat cerebral cortex. Kim KW; Son Y; Shin BS; Cho KP Life Sci; 2001 Feb; 68(11):1305-15. PubMed ID: 11233997 [TBL] [Abstract][Full Text] [Related]
23. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors. Oktem HA; Apaydin S Neurobiology (Bp); 1998; 6(3):323-32. PubMed ID: 9778651 [TBL] [Abstract][Full Text] [Related]
24. Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. Horwitz KB; Horwitz LD J Clin Invest; 1982 Apr; 69(4):750-8. PubMed ID: 6281310 [TBL] [Abstract][Full Text] [Related]
25. Competition by estrogens for catecholamine receptor binding in vitro. Paden CM; McEwen BS; Fishman J; Snyder L; DeGroff V J Neurochem; 1982 Aug; 39(2):512-20. PubMed ID: 7086432 [TBL] [Abstract][Full Text] [Related]
26. Changes in the binding characteristics of the mu, delta and kappa subtypes of the opioid receptor in the hypothalamus of the normal cyclic ewe and in the ovariectomised ewe following treatment with ovarian steroids. Thom B; Canny BJ; Cowley M; Wright PJ; Clarke IJ J Endocrinol; 1996 Jun; 149(3):509-18. PubMed ID: 8691110 [TBL] [Abstract][Full Text] [Related]
27. Adrenal steroids and the development of osteoporosis in oophorectomised women. Manolagas SC; Anderson DC; Lindsay R Lancet; 1979 Sep; 2(8143):597-600. PubMed ID: 90269 [TBL] [Abstract][Full Text] [Related]
28. Transport of equine estrogens: binding of conjugated and unconjugated equine estrogens with human serum proteins. Pan CC; Woolever CA; Bhavnani BR J Clin Endocrinol Metab; 1985 Sep; 61(3):499-507. PubMed ID: 4040531 [TBL] [Abstract][Full Text] [Related]
29. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome. Handelsman DJ; Teede HJ; Desai R; Norman RJ; Moran LJ Hum Reprod; 2017 Feb; 32(2):418-422. PubMed ID: 27999117 [TBL] [Abstract][Full Text] [Related]
30. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition. Liu-Chen LY; Yang HH; Li S; Adams JU J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074 [TBL] [Abstract][Full Text] [Related]
31. Interactions between laudanosine, GABA, and opioid subtype receptors: implication for laudanosine seizure activity. Katz Y; Weizman A; Pick CG; Pasternak GW; Liu L; Fonia O; Gavish M Brain Res; 1994 May; 646(2):235-41. PubMed ID: 8069669 [TBL] [Abstract][Full Text] [Related]
32. A monoclonal antibody recognizing kappa- but not mu- and delta-opioid receptors. Maderspach K; Németh K; Simon J; Benyhe S; Szücs M; Wollemann M J Neurochem; 1991 Jun; 56(6):1897-904. PubMed ID: 1851205 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and binding characteristics of tritiated TIPP[psi], a highly specific and stable delta opioid antagonist. Nevin ST; Tóth G; Weltrowska G; Schiller PW; Borsodi A Life Sci; 1995; 56(10):PL225-30. PubMed ID: 7885186 [TBL] [Abstract][Full Text] [Related]
34. Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain. Titeler M; Lyon RA; Kuhar MJ; Frost JF; Dannals RF; Leonhardt S; Bullock A; Rydelek LT; Price DL; Struble RG Eur J Pharmacol; 1989 Aug; 167(2):221-8. PubMed ID: 2556284 [TBL] [Abstract][Full Text] [Related]
35. Estrogens in maternal plasma following intraamniotic injection of (3H)-dehydroepiandrosterone-sulfate in midpregnancy. Lehmann WD; Strecker JR J Perinat Med; 1976; 4(4):255-60. PubMed ID: 137965 [TBL] [Abstract][Full Text] [Related]
36. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe. Stojilković SS; Dufau ML; Catt KJ Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471 [TBL] [Abstract][Full Text] [Related]
37. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. Emmerson PJ; Liu MR; Woods JH; Medzihradsky F J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478 [TBL] [Abstract][Full Text] [Related]
38. Analysis by LC-MS/MS of endogenous steroids from human serum, plasma, endometrium and endometriotic tissue. Häkkinen MR; Heinosalo T; Saarinen N; Linnanen T; Voutilainen R; Lakka T; Jääskeläinen J; Poutanen M; Auriola S J Pharm Biomed Anal; 2018 Apr; 152():165-172. PubMed ID: 29414008 [TBL] [Abstract][Full Text] [Related]
39. Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates. Lewanowitsch T; Irvine RJ Brain Res; 2003 Feb; 964(2):302-5. PubMed ID: 12576191 [TBL] [Abstract][Full Text] [Related]
40. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]